186P Elevated CXCL10:IL-8 ratio in bronchoalveolar lavage fluid of immune checkpoint inhibitor-related pneumonitis

P.T.L. Van Mol,A. Franken, S. Vanmassenhove, E. Donders, R. Schepers, T. van Brussel, C. Dooms, J. Yserbyt,N. De Crem,D. Testelmans,W. de Wever, K.L. Nackaerts, J.F. Vansteenkiste,R. Vos,D. Lambrechts,J. Naidoo,K. Suresh,S. Humblet-Baron, E. Wauters

Journal of Thoracic Oncology(2023)

引用 0|浏览0
暂无评分
摘要
Immune checkpoint inhibitor (ICI) pneumonitis is the most common fatal immune-related adverse event (irAE) from PD-1/ PD-L1 blockade, and a diagnosis of exclusion. Based on single-cell transcriptomics, we identified pathogenic T-helper 17.1 cells in ICI-pneumonitis bronchoalveolar lavage fluid (BALF), putatively engaging with pro-inflammatory “M1-like” monocytes, as a key pathophysiologic mechanism. Herein, we present the cytokine profile of ICI-pneumonitis BALF, aiming to identify further mechanistic insights and diagnostic biomarkers. Levels of 22 cytokines (GM-CSF, Granzyme B, IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-13, IL-15, IL-17A, IP-10, MCP-1, MIP-1α, MIP-1β, Perforin, sCD137, TNF-α, TNF-β) were measured in BALF supernatant of 17 ICI-pneumonitis and 6 controls from 23 independent patients at UZ Leuven (discovery), using Isoplexis’ CodePlex platform. Validation was performed in a published cohort of 13 ICI-pneumonitis and 6 controls from independent patients at Johns Hopkins University. Mann-Whitney U test (Benjamini-Hochberg corrected) was used to compare cytokine levels between groups. In the discovery cohort, we observed significantly lower levels of IL-8, IL-9, IL-10, IL-17A, CCL2, and sCD137 in ICI-pneumonitis BALF vs. controls. There was a trend towards higher levels of TNF-α and CXCL10 (p = 0.11; p = 0.16 respectively). Next, we investigated the biomarker potential of ratios of differentially abundant proteins, arguing that disbalance rather than absolute cytokine values provides a more meaningful readout for inflammation, while correcting for technical variability in BALF-derived data. We identified that a high CXCL10: IL-8 ratio distinguishes ICI-pneumonitis from control patients in the discovery cohort (ROC AUC 0.92) and in the validation cohort (ROC AUC 0.82). Bulk cytokine profiling identifies a high CXCL10: IL-8 ratio as a reproducible characteristic of ICI-pneumonitis BALF, in line with immunophenotypic data suggesting an interferon-γ driven immune response and absence of neutrophilic inflammation, respectively. The diagnostic utility of the CXCL10: IL-8 ratio in BALF to identify ICI-pneumonitis should be further investigated.
更多
查看译文
关键词
bronchoalveolar lavage fluid,inhibitor-related
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要